Bar J - Search Results

1

Neo-adjuvant Chemo-Radiation to 60 Gray Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer Patients: Evaluation of Trimodality Strategy.

Appel S, Goldstein J, Perelman M, Rabin T, Urban D, Onn A, Shulimzon TR, Weiss I, Lieberman S, Marom EM, Golan N, Simansky D, Ben-Nun A, Lawrence YR, Bar J, Symon Z. Appel S, et al. Among authors: bar j. Isr Med Assoc J. 2017 Oct;19(10):614-619. Isr Med Assoc J. 2017. PMID: 29103238 Free article.

2

Combined anti-proliferative and anti-angiogenic strategies for cancer.

Bar J, Onn A. Bar J, et al. Expert Opin Pharmacother. 2008 Apr;9(5):701-15. doi: 10.1517/14656566.9.5.701. Expert Opin Pharmacother. 2008. PMID: 18345949 Review.

3

Cancer cells suppress p53 in adjacent fibroblasts.

Bar J, Feniger-Barish R, Lukashchuk N, Shaham H, Moskovits N, Goldfinger N, Simansky D, Perlman M, Papa M, Yosepovich A, Rechavi G, Rotter V, Oren M. Bar J, et al. Oncogene. 2009 Feb 12;28(6):933-6. doi: 10.1038/onc.2008.445. Epub 2008 Dec 8. Oncogene. 2009. PMID: 19060923 Free PMC article.

4

Multitargeted inhibitors in lung cancer: new clinical data.

Bar J, Herbst RS, Onn A. Bar J, et al. Clin Lung Cancer. 2008;9 Suppl 3:S92-9. doi: 10.3816/CLC.2008.s.014. Clin Lung Cancer. 2008. PMID: 19419930 Review.

5

Targeted drug delivery strategies to treat lung metastasis.

Bar J, Herbst RS, Onn A. Bar J, et al. Expert Opin Drug Deliv. 2009 Oct;6(10):1003-16. doi: 10.1517/17425240903167926. Expert Opin Drug Deliv. 2009. PMID: 19663628 Review.

6

Breast cancer HER2 equivocal cases: is there an alternative to FISH testing? A pilot study using two different antibodies sequentially.

Yosepovich A, Avivi C, Bar J, Polak-Charcon S, Mardoukh C, Barshack I. Yosepovich A, et al. Among authors: bar j. Isr Med Assoc J. 2010 Jun;12(6):353-6. Isr Med Assoc J. 2010. PMID: 20928989 Free article.

7

Overcoming molecular mechanisms of resistance to first-generation epidermal growth factor receptor tyrosine kinase inhibitors.

Bar J, Onn A. Bar J, et al. Clin Lung Cancer. 2012 Jul;13(4):267-79. doi: 10.1016/j.cllc.2011.09.001. Epub 2011 Dec 9. Clin Lung Cancer. 2012. PMID: 22154113

8

Anti-angiogenic treatments in advanced NSCLC: back to the drawing board.

Bar J, Shiran I, Urban D, Agbarya A, Onn A. Bar J, et al. J Thorac Dis. 2012 Dec;4(6):643-6. doi: 10.3978/j.issn.2072-1439.2012.10.11. J Thorac Dis. 2012. PMID: 23205293 Free PMC article. No abstract available.

9

Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.

Urban D, Bar J, Solomon B, Ball D. Urban D, et al. Among authors: bar j. J Thorac Oncol. 2013 Jul;8(7):940-6. doi: 10.1097/JTO.0b013e318292c53e. J Thorac Oncol. 2013. PMID: 23695418 Free article.

10

Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimens.

Bar J, Damianovich M, Hout Siloni G, Dar E, Cohen Y, Perelman M, Ben Nun A, Simansky D, Yellin A, Urban D, Onn A. Bar J, et al. Clin Lung Cancer. 2014 Mar;15(2):159-65. doi: 10.1016/j.cllc.2013.11.005. Epub 2013 Nov 14. Clin Lung Cancer. 2014. PMID: 24370118 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

632 results

Search Page

Filters